Allergy expert Dr Hugh Sampson joing DBV Technologies
July 9, 2015Research and Development DBV Technologies, Viaskin
DBV Technologies has appointed Dr Hugh Sampson as its chief scientific officer. The French biotech company is developing the Viaskin peanut allergy treatment patch. Dr …
Praluent scores positive trial results in Japan
July 9, 2015Research and Development Japan, PCKS9, Regeneron, Sanofi, heart disease, high cholesterol, praluent
Praluent, the new heart drug from Sanofi and Regeneron, has met its primary endpoint in a Phase III study in …
Actavis contraceptives recalled after packaging errors
July 9, 2015Manufacturing and Production Actavis, FDA, manufacturing, packaging, product recall, production, recalls
Actavis is voluntarily recalling more than half a million boxes of contraceptive pills in the United States due to problems …
Horizon attempts a hostile $3bn Depomed takeover
July 9, 2015Manufacturing and Production, Research and Development, Sales and Marketing Depomed, M&A, MA, acquisitions, horizon, mergers, takeover
Dublin-based specialty pharmaceutical company Horizon has launched a bid to buy Depomed for $3 billion. Horizon, a biopharma company focussed …
Conservative announce NHS to receive a further £8 billion by 2020
July 9, 2015Budget, Chancellor, Chancellor of the exchequer, Conservatives, George Osborne, NHS, NHS funding, Tories, funding, government
The Conservative Government has confirmed the NHS will receive £10 billion in funding by 2020 in the Chancellor’s budget announcement.The …
Pegasus appoints two new members to its pharma team
July 8, 2015Medical Communications Pegasus
The health communications consultancy Pegasus is expanding its pharma and life sciences division, with the appointment of two new members …
Novartis wins US nod for new heart drug
July 8, 2015Research and Development, Sales and Marketing Entestro, FDA, LCZ696, Novartis, ejection fraction, heart failure, reduced ejection fraction, sacubitril
The FDA has given the green light to Novartis’ new heart failure drug, six weeks ahead of the scheduled date …
23andMe targets $150 million for drug development
July 8, 2015Research and Development 23andME, DNA, DNA testing, genetics, venture capital
The genetic testing firm 23andMe is seeking to raise $150 million in order to move into its own drug development …
European medicines group appoints Bayer’s Alex Moscho as new chair
July 7, 2015Manufacturing and Production, Research and Development, Sales and Marketing Alexander Moscho, EMG, European Medicines Group
Leading UK industry group the European Medicines Group (EMG) has elected Dr Alexander Moscho, the managing director of Bayer UK …
Pharma ‘paid US doctors $1.5 billion’ in 2014
July 7, 2015Medical Communications, Sales and Marketing Sunshine Act, US, pharma
Some of the largest European drugmakers paid US doctors and teaching hospitals $1.5 billion in 2014 to participate in promotional …
Teva ‘to increase Mylan bid to $43bn’
July 7, 2015Sales and Marketing M&A, MA, Mylan, Teva, generics
Israeli drugmaker Teva is considering whether to up its bid for US rival firm Mylan, with reports that it could …
Prescribing in England up 55% to £9bn over a decade
July 7, 2015Manufacturing and Production, Sales and Marketing NHS, NHSIC, drugs, health and social care information centre, net ingredient cost, prescribing
The number of drugs issued in England continues to soar, according to the latest NHS figures which show prescribing in …
Biogen to build billion-dollar plant in Switzerland
July 7, 2015Manufacturing and Production Alzherimer's disease, Biogen, Biogen IDEC, MS, Switzerland, manufacturing, multiple sclerosis
Biogen plans to open a $1 billion manufacturing facility in Switzerland, to help Europe deal with the future demand for …
Novo Nordisk pulls Tresiba in Germany after pricing row
July 6, 2015Manufacturing and Production, Sales and Marketing Drug pricing, Germany, Novo Nordisk, Reimbursement, Tresiba, market access
Novo Nordisk has discontinued its distribution of once-daily basal insulin Tresiba after pricing talks with the German body that represents …
Working Life: Bayer UK & Ireland’s chief executive Alexander Moscho
July 6, 2015Manufacturing and Production, Research and Development, Sales and Marketing Alexander Moscho, Bayer
How did you find your way into your current role?I think it started when I was young and I was …
Adam Zaeske appointed as managing director of Takeda UK and Ireland
July 6, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adam Zaeske, Takeda
Japanese pharma firm Takeda has appointed Adam Zaeske as managing director of Takeda UK and Ireland.Zaeske has been with Takeda …
NHS England approves AbbVie’s Duodopa for Parkinson’s disease
July 6, 2015Sales and Marketing AbbVie, Duodopa, James Palmer, NHS England, PPRS, Parkinson's, Parkinson's disease, commissioning
AbbVie has been handed a boost by NHS England, who has approved the prescribing of its Parkinson’s disease treatment Duodopa …
Vertex’s cystic fibrosis drug gets FDA approval
July 3, 2015Research and Development, Sales and Marketing FDA, Orkambi, Vertex, cystic fibrosis, gene therapy
Vertex Pharmaceuticals cystic-fibrosis drug Orkambi, which could treat as many as 8,500 patients in the US, has been approved by …
Sanofi’s Toujeo approved in Japan
July 3, 2015Manufacturing and Production, Sales and Marketing Japan, Lantus Lantus XR, Sanofi, diabetes, toujeo, type diabetes
The Ministry of Health, Labor and Welfare in Japan has given Sanofi a marketing authorisation for the diabetes drug the …
Astellas in ‘unacceptable’ Xtandi ABPI code breach
July 3, 2015Medical Communications, Sales and Marketing ABPI Code, Astella, PMCPA, Xtandi
The industry code of conduct regulator has singled out Astellas for ‘particular censure’ for arranging a meeting for UK healthcare …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
